Tyrosine Kinase Inhibitors - Globe Thesis

Keyword [Tyrosine Kinase Inhibitors] Result: 161 - 180 \| Page: 9 of 10
161.	EGFR Mutations In Patients With Advanced NSCLC Complicated With COPD And The Response And Prognosis Of EGFR-TKIs Treatment
162.	A bio-organic approach to the design and synthesis of tyrosine kinase inhibitors with multi-modal imaging capabilities
163.	Active transport and CNS delivery of novel tyrosine kinase inhibitors
164.	The effect of photodynamic therapy (PDT) on epidermal growth factor receptor and interleukin-6 cytokine signaling, and tyrosine kinase inhibitors enhance the efficacy of PDT by increasing intracellular accumulation of photosensitizers
165.	Targeting EGFR and ErbB2 by small molecule tyrosine kinase inhibitors in human colon cancer
166.	Design and synthesis of protein-tyrosine kinase inhibitors
167.	Changing the Drug Exposure of Small Molecule Tyrosine Kinase Inhibitors
168.	Clinical Characteristics Of Hypertension Induced By VEGF Pathway Inhibitors And Its Related Mechanism
169.	Study On The Role Of MiR-873 In The Reversing Effect Of Intercalated Treatment In Lung Cancer Patients With Acquired Resistance To EGFR Tyrosine Kinase Inhibitors
170.	Treatment Strategy Refinement For Advanced Non-small Cell Lung Cancer In Different Subgroups
171.	MiR-206 Involved In Gefitinib Acquired Drug-resistance In Non-small Cell Lung Cancer Patients Through Modulating IL-6 Expression
172.	Clinical Outcomes And Optimal Treatment Strategy Of Epidermal Growth Factor Receptor Gene Mutated Locally Advanced Non-Small Cell Lung Cancer
173.	Design, Synthesis And Biological Activity Of Novel Acenaphtho "1,2-b"Pyrrole And Naphthalimide Antitumor Agents
174.	The Molecular Mechanism Underlying The Inhibitory Effect Of Tyrosine Kinase Inhibitors On HERG Potassium Crrent
175.	Design,Syntheses And Antitumor Activity Of Novel Small Photosensitizers Based On Chlorin Skeleton
176.	Study On The Molecular Mechanism Of Hypothyroidism Induced By Tyrosine Kinase Inhibitors
177.	Application Value Of EGFR Mutant Protein Expression In Targeted Therapy With Tyrosine Kinase Inhibitors In Advanced Lung Adenocarcinoma
178.	B7-H3 As A Predictor Of Clinical Outcome In Lung Adenocarcinoma Patients Treated With EGFR Tyrosine Kinase Inhibitors
179.	Evaluation Of The Efficacy And Safety Of Anlotinib In The Treatment Of Advanced Non-Small Cell Lung Cancer
180.	Clinical Characteristics And Efficacy Analysis Of TKIs Combined With Chemotherapy In The Treatment Of Adult Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
<<First <Prev Next> Last>> Jump to